RESEARCH TRIANGLE PARK, N.C., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, and Richard I. Eisenstadt, Vice President, Finance and CFO, will present at the Canaccord Genuity 32nd Annual Growth Conference taking place at the Intercontinental Hotel in Boston, MA August 14-16, 2012. Tranzyme’s presentation is scheduled for Tuesday, August 14th at 1:00 pm ET in the Vancouver Room followed by a breakout session.
